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Background: Duodenal involvement occurs frequently in gallbladder cancer (GBC) as a result of the
proximity of the duodenum to the gallbladder.
Methods: The study group included 74 GBC patients assessed between August 2009 and March 2011
in whom computed tomography (CT) of the abdomen indicated suspicion for duodenal involvement.
Results: Of 172 patients with resectable GBC, 74 (43.0%) had suspected duodenal involvement on
imaging. Of these, 51 (68.9%) had suspected duodenal involvement on upper gastrointestinal endoscopy
(UGIE). Symptoms of gastric outlet obstruction (GOO) were present in only 14 (18.9%) patients. Thirteen
(17.6%) patients underwent staging laparoscopy alone. Of the 61 patients who underwent laparotomy, 31
(50.8%) were found to have actual duodenal involvement. The positive predictive value (PPV) of CT of the
abdomen for duodenal involvement was 50.8% (31 of 61 patients). The addition of UGIE increased the
PPV to 65.9% (27 of 41 patients). In the subgroup with evidence of duodenal mural thickening or mucosal
irregularity on CT of the abdomen (n = 9) or duodenal mucosal infiltration on UGIE (n = 14), the PPV
increased to 100%. A total of 33 (44.6%) patients underwent curative resection. The resectability rate was
significantly lower in patients with symptoms of GOO [two of 14 (14.3%) vs. 31 of 60 (51.7%); P = 0.010],
CT findings of duodenal mural thickening or mucosal irregularity compared with only loss of the fat plane
[two of 12 (16.7%) vs. 31 of 62 (50.0%); P = 0.032], and UGIE evidence of duodenal infiltration compared
with extrinsic compression or normal endoscopic findings [three of 16 (18.8%) vs. 18 of 35 (51.4%) and
12 of 23 (52.2%), respectively; P = 0.027 and P = 0.036, respectively].
Conclusions: Overall, CT of the abdomen demonstrated a PPV of 50.8% in detecting duodenal involve-
ment, which increased to 65.9% with the addition of UGIE. The combined presence of GOO symptoms,
CT findings of duodenal mural thickening and mucosal irregularity, and UGIE findings of infiltration of the
duodenal mucosa significantly decreases resectability but does not preclude resection.
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Introduction
Gallbladder cancer (GBC) is the most common malignancy of the
biliary tract and frequently presents at an advanced stage with
adjacent organ involvement.1 Although the liver is the most com-
monly involved adjacent organ, duodenal involvement occurs fre-
quently as a result of the proximity of the duodenum to the
gallbladder.2 Whereas some authors have considered duodenal
involvement in GBC to represent a sign of unresectable advanced
disease, others have shown that radical resection improves sur-
vival in these patients.3–7 However, there is controversy in the
literature regarding the extent of resection, which ranges from
limited resection of the stomach and duodenum to hepatopancre-
atoduodenectomy (HPD).5–7 Although limited resection of the
stomach and duodenum can be performed with minimal morbid-
ity, HPD is associated with significant morbidity and mortality.7
Cross-sectional imaging [computed tomography (CT) of the
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abdomen, magnetic resonance imaging (MRI) of the abdomen]
and upper gastrointestinal endoscopy (UGIE) are commonly used
investigations to detect duodenal involvement.7–10 It is of para-
mount importance to ascertain whether and to what extent the
duodenum is infiltrated by the tumour in order to establish a
management strategy. However, the data available on the accuracy
of these investigations to predict actual duodenal involvement are
limited. Hence, this study was undertaken to assess the predictive
value of imaging and UGIE in detecting duodenal involvement.
The significance of duodenal involvement on preoperative evalu-
ation was assessed by correlating such findings with resectability
rates and extents of surgery.
Materials and methods
This was a prospective study conducted over 20 months from
August 2009 to March 2011. All patients suspected to have GBC
underwent an ultrasound examination of the abdomen. Patients
without evidence of dissemination underwent a dual-phase CT
scan of the abdomen using a 16-slice CT scanner. Patients in
whom CT showed suspicions of duodenal involvement formed
the study group. These patients were further evaluated with UGIE
followed by staging laparoscopy (SL). The criterion for duodenal
involvement on dual-phase CT of the abdomen was defined as loss
of the fat plane between the gallbladder mass and the duodenum
with or without evidence of duodenal mural thickening and
mucosal irregularity (Figs 1 and 2). These patients were further
evaluated with UGIE. Findings on UGIE were classified as normal,
demonstrative of extrinsic compression without mucosal involve-
ment, or indicative of obvious tumour infiltration into the duode-
nal lumen with or without complete gastric outlet obstruction
(GOO) (Fig. 3). Endoscopic biopsy was taken when there was
evidence of tumour infiltration into the duodenum on UGIE.
All patients deemed resectable on preoperative imaging under-
went an SL prior to a laparotomy. Suspicious metastatic lesions on
SL were biopsied and confirmed by frozen-section analysis. Pal-
liative gastrojejunostomy (GJ) was performed in patients symp-
tomatic for GOO (Fig. 3). In patients in whom no metastatic
disease was found on SL, laparotomy was performed through a
right subcostal incision. Routine sampling of inter-aortocaval
lymph nodes was performed in all patients and a positive result on
frozen-section histopathology was considered to indicate meta-
static disease and the resection was abandoned. The type of resec-
tion was determined by the loco-regional extent of the tumour
according to liver and adjacent organ infiltration (Fig. 4). In
patients with limited duodenal involvement, a sleeve resection of
the duodenum was performed. In patients with more extensive
involvement (without pancreatic infiltration) and those in whom
a luminal compromise was expected after sleeve resection of the
duodenum, a distal gastrectomy with proximal duodenectomy
(DGPD) was performed. This included resection of a variable
length of the first and suprapapillary portion of the second part of
the duodenum (depending upon the extent of duodenal involve-
ment). Bowel continuity in these patients was restored by a gas-
trojejunostomy. Patients with limited pancreatic infiltration
underwent a wedge resection of the pancreas. Patients with more
extensive pancreatic involvement or involvement of the duodenal
(a) (b)
Figure 1 (a,b) Computed tomography (CT) of the abdomen showing only loss of the fat plane between the gallbladder mass and the
duodenum without mural thickening (arrow)
Figure 2 Computed tomography (CT) of the abdomen showing loss
of the fat plane between the gallbladder mass and the duodenum
with mural thickening and mucosal irregularity (arrow)
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papilla underwent an HPD. Common bile duct (CBD) excision
was selectively performed when there was direct infiltration or
extensive nodal disease in the hepatoduodenal ligament and in
patients with GBC with an underlying choledochal cyst. Patients
with colonic involvement underwent either a limited colonic
resection or a right hemicolectomy depending upon the extent of
colonic infiltration. Standard lymphadenectomy was performed
in all patients. This included the clearance of nodes in the hepa-
toduodenal ligament, nodes anterior and posterior to the head of
the pancreas, and nodes along the hepatic artery until its origin
from the coeliac axis. Symptoms of GOO, CT scan findings and
UGIE findings were correlated with intraoperative findings and
resectability rates in these patients. Statistical analysis was per-
formed using GraphPad instat Version 4 (GraphPad Software,
Inc., La Jolla, CA, USA). Categorical variables were summarized
using proportions and were compared using Fisher’s exact test. A
P-value of <0.05 was considered to indicate statistical significance.
Results
During the study period, 318 patients with GBC were assessed for
operability. Of these, 146 (45.9%) patients were deemed to be
unresectable according to either metastatic disease or poor general
condition. Of the 172 patients considered to be resectable on
preoperative imaging, 74 (43.0%) demonstrated suspicions of
duodenal involvement on CT of the abdomen; these patients rep-
resented the study group. The mean  standard deviation (SD)
age in this group was 53.4 8.3 years (range: 29–86 years). A total
of 59 (79.7%) patients were female (female : male ratio: 3.9:1).
Abdominal pain was the most common clinical symptom and was
reported by 100% of patients. Symptoms suggestive of GOO were
present in 14 (18.9%) patients and jaundice was present in 16
(21.6%) patients (Table 1).
On CT scan of the abdomen, all 74 patients were found to have
loss of the fat plane between the GB mass and the duodenum.
Twelve (16.2%) patients also had duodenal mural thickening with
mucosal irregularity. Examination by UGIE revealed extrinsic
compression without mucosal involvement in 35 (47.3%) patients
and obvious infiltration of the tumour into the duodenal lumen
with or without complete luminal obstruction in 16 (21.6%)
patients. The remaining 23 (31.1%) patients demonstrated
normal findings on UGIE (Table 2). Of the 74 patients who
underwent SL, 24 (32.4%) were found to have disseminated
disease in the form of surface liver metastasis (n = 10) or perito-
neal deposits (n = 14). Of these, 11 patients with symptoms of
GOO underwent palliative GJ and 13 patients in whom duodenal
infiltration by the tumour could not be assessed did not undergo
any further procedure. Hence, intraoperative assessment for
duodenal involvement was possible in only 61 (82.4%) patients,
31 (50.8%) of whom were found to have actual duodenal involve-
ment by the GBC. Using CT scan findings to correlate with intra-
operative assessment, if only loss of the fat plane was taken as the
criterion for duodenal involvement, the positive predictive value
(PPV) was 50.8% (31 of 61 patients). The PPVs of duodenal
mural thickening with mucosal irregularity on CT of the
abdomen, and extrinsic compression and obvious infiltration of
the tumour into the duodenal lumen on UGIE are summarized in
Table 2.
Types of surgery performed and overall resectability rates in
these patients are summarized in Table 3. Of the 74 patients who
underwent SL, 24 (32.4%) had disseminated disease. Of these 24
patients, 13 underwent SL alone because they did not require
palliation and the remaining 11 patients underwent laparotomy to
achieve a palliative GJ. Of the 50 patients who underwent laparo-
tomy with curative intent, 17 (34.0%) were found to have
unresectable disease as a result of liver metastasis (n = 1), inter-
aortocaval lymph node metastasis (n = 7) or locally advanced
unresectable disease (n = 9). Overall, curative resection was
performed in 33 (44.6%) patients. Radical cholecystectomy with
resection of segments IVb and V was performed in 31 patients,
resection of segments IVb, V and VI was performed in one patient
and extended right hepatectomy was performed in one patient.
Standard lymphadenectomy (as previously described) was per-
formed in all patients. Of the 33 patients who underwent curative
resection, 18 were found to have duodenal involvement on intra-
operative assessment. Eight patients in whom a small area of
contact with the duodenum was identified underwent a duodenal
sleeve resection; 10 patients in whom the area of contact with the
duodenum was wide underwent a DGPD. A wedge resection of
the pancreas was performed in two patients with limited pancre-
atic infiltration. Indications for CBD excision and types of colonic
resection are summarized in Table 3. A palliative procedure was
performed in 19 patients, of whom 17 underwent a GJ alone and
two underwent an additional ileo-transverse bypass performed to
palliate obstruction of the large bowel secondary to infiltration of
the hepatic flexure.
Figure 3 Upper gastrointestinal endoscopy showing mucosal infil-
tration with luminal narrowing
HPB 205
HPB 2013, 15, 203–209 © 2012 International Hepato-Pancreato-Biliary Association
The significance of duodenal involvement was analysed by
correlating resectability rates with symptoms, and CT and UGIE
findings (Table 4). The resectability rate was significantly lower
in patients with symptoms of GOO compared with patients
without these symptoms [two of 14 (14.3%) vs. 31 of 60
(51.7%); P = 0.010]. Correlations of findings in CT scans of the
abdomen showed the resectability rate to be lower in patients
with mural thickening and mucosal irregularity compared with
those with only loss of the fat plane between the gallbladder
mass and the duodenum [two of 12 (16.7%) vs. 31 of 62
(50.0%); P = 0.032]. Patients with evidence of duodenal involve-
ment on CT combined with mucosal infiltration on UGIE had a
significantly lower resectability rate than patients with only CT
evidence of duodenal involvement [three of 16 (18.8%) vs. 12 of
23 (52.2%); P = 0.036] or CT evidence with extrinsic compres-
sion on UGIE [three of 16 (18.8%) vs. 18 of 35 (51.4%); P =
0.027]. An analysis of the causes of unresectability showed the
incidence of metastatic disease to be significantly higher in
patients with imaging evidence of duodenal involvement and
endoscopic evidence of duodenal infiltration compared with
patients with an extrinsic bulge or a normal endoscopy [11 of 16
(68.8%) vs. 21 of 58 (36.2%); P = 0.020]. After excluding
patients with metastatic disease, the incidence of locally
advanced unresectable disease was higher in patients with endo-
scopic evidence of duodenal infiltration than in patients with an
extrinsic bulge or a normal endoscopy [two of five (40.0%) vs.
seven of 37 (18.9%)], although this difference did not reach
statistical significance (P = 0.288).
Suspected duodenal
involvement on imaging
UGIE to assess duodenal
involvement
Staging laparoscopy to










Distal gastrectomy with 
proximal duodenectomy
Small area of contact Wide area of contact




Figure 4 Algorithm for the management of gallbladder cancer patients with suspected duodenal involvement on imaging. UGIE, upper
gastrointestinal endoscopy
Table 1 Demographics and clinical features of gallbladder cancer
patients with duodenal involvement on imaging (n = 74)
Clinical parameter
Age, years, mean  SD 53.4  8.3
Sex, male : female 1:3.9
Abdominal pain 100% (74/74)
Gastric outlet obstruction 18.9% (14/74)
Jaundice 21.6% (16/74)
Anorexia/weight loss 94.6% (70/74)
Palpable gallbladder mass 64.9% (48/74)
SD, standard deviation.
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Discussion
Although the liver is the most commonly involved adjacent organ,
duodenal involvement occurs frequently in patients with GBC as
a result of the proximity of the duodenum to the gallbladder.2
Cross-sectional imaging in the form of CT or MRI of the
abdomen and UGIE are commonly used to diagnose duodenal
involvement preoperatively in patients with GBC.7–10 There is,
however, only limited evidence in the available literature on the
accuracy of preoperative investigations in predicting duodenal
involvement. Some reports have considered duodenal involve-
ment as a sign of unresectable advanced disease.3,4,11 Others have
considered it as an indication for extensive surgery in the form of
HPD, a procedure which has been reported to incur significant
morbidity and mortality.5,6 It has been previously reported that
duodenal involvement alone should not be considered as a sign of
unresectable disease and that a negative margin (R0) resection can
be achieved in many of these patients by performing a duodenal
sleeve resection or DGPD.7 Hence, the present study was con-
ducted to prospectively analyse the accuracy of preoperative
assessment of duodenal involvement based on symptoms,
imaging and UGIE and to ascertain its management implications.
Clinically, patients with duodenal involvement may present
with symptoms of GOO manifested by vomiting. The information
available in the literature on the predictive value of clinical symp-
toms for duodenal involvement is limited. In the present study, all
patients with symptoms of GOO in whom an intraoperative
assessment was possible showed evidence of duodenal involve-
Table 2 Positive predictive value of preoperative investigations for duodenal involvement












Computed tomography of the abdomen
Loss of fat plane 74 61 31 50.8%
Duodenal mural thickening with mucosal irregularity 12 9 9 100%
Upper gastrointestinal endoscopy
Overall 51 41 27 65.9%
Extrinsic compression 35 27 13 48.2%
Duodenal infiltration 16 14 14 100%
Table 3 Extent of resection in patients who underwent curative
resection (n = 33)
Extent of resection Patients, n
Liver resection
Segments IVb and V 31
Segments IVb, V and VI/extended right hepatectomy 2
Duodenal involvement 18
Duodenal sleeve resection 8
Distal gastrectomy with proximal duodenectomy 10
Wedge pancreatectomy 2
Common bile duct excision 13
Common bile duct involvement with jaundice 5
Choledochal cyst 2
Positive cystic duct margin 2
Lymph node clearance 4
Colon resection
Segmental colectomy/right hemicolectomy 7
Table 4 Correlations of resectability rate with symptoms and find-





Symptoms of gastric outlet
obstruction
Present (n = 14) 14.3% (2/14) 0.010
Absent (n = 60) 51.7% (31/60)
CT findings
Loss of fat plane/mural
thickening (n = 74)
44.6% (33/74) 0.032a
Only loss of fat plane (n = 62) 50.0% (31/62)






CT involvement + normal UGIE 52.2% (12/23) 0.584b
CT involvement + extrinsic
compression on UGIE
51.4% (18/35) 0.027c
CT involvement + duodenal
mucosal infiltration
18.8% (3/16) 0.036d
aOnly loss of fat plane vs. loss of fat plane with duodenal mural thickening
with mucosal irregularity.
bCT involvement + normal UGIE vs. CT involvement + extrinsic compres-
sion on UGIE.
cCT involvement + extrinsic compression on UGIE vs. CT involvement +
duodenal mucosal infiltration.
dCT involvement + normal UGIE vs. CT involvement + duodenal mucosal
infiltration.
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ment. By contrast, not all patients with imaging and endoscopic
evidence of duodenal mucosal infiltration had symptoms of GOO
(n = 2). To summarize, although the presence of complete GOO
symptoms had high PPV for detecting duodenal involvement, the
absence of GOO symptoms does not exclude it.
Computed tomography of the abdomen is commonly used in
the staging of GBC. Yoshimitsu et al. reported an accuracy of
83–86% for stage T2 disease and above, but reported poor sensi-
tivity for T1 lesions.12 Kim et al. reported an overall accuracy of
71% for assessing T-stage in 100 consecutive patients with GBC.8
However, few studies have focused on assessing the accuracy of CT
of the abdomen in detecting duodenal involvement. The criterion
most commonly used in these studies is loss of the fat plane
between the gallbladder mass and the duodenum. Ohtani et al.
reported a sensitivity of 57% for detecting duodenal involvement
on a CT scan based on an analysis of seven patients with GBC.13
Kalra et al. reported an accuracy of 85% for detecting duodenal
involvement, based on an analysis of 11 patients.9 In the present
study, when loss of the fat plane between the gallbladder tumour
and the duodenum on CT was used as the sole criterion for
predicting duodenal involvement, the PPV was 50.8%. However,
when duodenal mural thickening with mucosal irregularity was
used as an additional criterion to loss of the fat plane, the PPV rose
to 100% in the small subgroup of nine patients.
Upper gastrointestinal endoscopy is commonly used to confirm
the finding of suspected duodenal involvement on imaging.
However, current data on the predictive value of endoscopic find-
ings are limited. In UGIE, duodenal involvement may be seen as
either an extrinsic compression or infiltration of the duodenal
mucosa. In the current study, the presence of extrinsic compres-
sion alone had a PPV of 48.1%, which increased to 100% when
there was infiltration of the duodenal mucosa. This may reflect a
large gallbladder tumour that abuts or indents the duodenum
without actually infiltrating it. This finding (extrinsic compres-
sion) is significant because curative resection can be performed in
many of these patients without adding a duodenal sleeve resection
or DGPD.
In order to ascertain the significance of preoperative assessment
of duodenal involvement, findings on preoperative evaluation
were correlated with resectability rates. Some previous studies
have suggested that the presence of GOO symptoms is indicative
of advanced disease and that only palliative therapy is indi-
cated.3,4,11 In the present study, patients with symptoms of GOO
had a lower resectability rate than those without these symptoms
(14.3% vs. 51.7%; P = 0.010). However, two of the 14 patients with
complete GOO symptoms underwent curative resection and
hence the presence of GOO symptoms should not be considered a
sign of unresectability in isolation. The correlation of CT and
UGIE findings with resectability rates showed that resectability
rates in patients with evidence of duodenal involvement on CT
combined with mucosal infiltration on UGIE were significantly
lower than those in patients with only CT evidence of duodenal
involvement (18.8% vs. 52.2%; P = 0.036) or CT evidence with
extrinsic compression on UGIE (18.8% vs. 51.4%; P = 0.027). An
analysis of the causes of unresectability showed the frequency of
metastatic disease was significantly higher in patients with endo-
scopic evidence of duodenal mucosal infiltration compared with
patients with an extrinsic bulge or normal endoscopy (68.8% vs.
36.2%; P = 0.020). To summarize, the presence of symptoms of
GOO, and evidence of duodenal mural thickening with mucosal
irregularity on CT of the abdomen and mucosal infiltration on
UGIE have a high PPV for duodenal involvement and are associ-
ated with a higher incidence of metastatic disease and a signifi-
cantly lower rate of resectability.
There is heterogeneity in the literature regarding the magnitude
of surgery required in patients with GBC with duodenal involve-
ment. Moreover, the majority of published studies have analysed
simultaneous duodenopancreatic involvement and have advo-
cated an HPD in all such instances.14,15 This procedure, however,
has been reported to be associated with high rates of morbidity
and mortality. Ogura et al. analysed 1686 patients with GBC who
underwent resection in 172 major hospitals in Japan.16 Of these,
150 patients underwent HPD, in which the overall rate of major
complications was 54%.16 A previous study reported that duode-
nal sleeve resection or DGPD can be safely performed in such
patients with minimal morbidity and equivalent longterm sur-
vival.7 Kondo et al. also described sleeve resection of the duode-
num in GBC with limited duodenal involvement.17 In the present
series, of the 18 patients with actual duodenal involvement, R0
resection was achieved in eight patients by performing a duodenal
sleeve resection and in 10 by DGPD. In a significant proportion
of patients with combined duodenopancreatic involvement, a
DGPD with a wedge of pancreas can achieve an R0 resection and
avoid an HPD. Hirano et al. compared operative and longterm
outcomes in patients who underwent wedge resection (n = 9) and
HPD (n = 8) and found no differences in local recurrence or
cumulative survival rates.18 In the present series, two patients with
limited pancreatic involvement were managed with wedge resec-
tion of the pancreas without substantially increasing the morbid-
ity associated with the procedure.
Conclusions
In the present study, CT of the abdomen was found to have a
PPV of 50.8% in detecting duodenal involvement. The addition
of UGIE in these patients increased the PPV to 65.9%. In the
subgroup with duodenal mural thickening and mucosal irregu-
larity on CT of the abdomen, and duodenal mucosal infiltration
on UGIE, the PPV increased to 100%. The presence of symp-
toms suggestive of complete GOO, duodenal mural thickening
or mucosal irregularity on CT of the abdomen and infiltration
of the duodenal mucosa on UGIE significantly decreases resec-
tability in these patients, but does not preclude resection. In the
majority of patients with actual duodenal infiltration, R0 resec-
tion can be achieved with limited resection of the stomach and
duodenum.
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